Try our beta test site

Safety and Efficacy of AEB071 in Metastatic Uveal Melanoma Patients

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )
ClinicalTrials.gov Identifier:
NCT01430416
First received: September 6, 2011
Last updated: February 13, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 15, 2017
  Estimated Primary Completion Date: July 15, 2017 (Final data collection date for primary outcome measure)